Enveda Biosciences combines artificial intelligence, machine learning, and natural product chemistry to discover new drugs from nature. The company uses computational approaches to analyze traditional medicines and natural compounds, identifying potential therapeutic targets and drug candidates. Enveda's platform integrates metabolomics, genomics, and AI to accelerate the drug discovery process by learning from indigenous knowledge and natural biodiversity.
Enveda Biosciences has received investment from 1 venture capital firm.
AI-driven drug discovery company that mines natural products and traditional medicines to develop new pharmaceuticals.
Enveda Biosciences has received investment from Dimension. These venture capital firms and investors provide both capital and strategic support.
Enveda Biosciences has raised $175M in total funding, with their most recent round being a Series B. The company operates in the Biotech sector.
Enveda Biosciences was founded in 2019 and is headquartered in Boulder, Colorado.
Enveda Biosciences operates in the Biotech sector. AI-driven drug discovery company that mines natural products and traditional medicines to develop new pharmaceuticals.
